| For: | Xue H, Li H, Ju LL, Han XD, Cheng TC, Luo X, Chen L, Shao JG, She YJ, Bian ZL. Mucosal-associated invariant T cells in hepatitis B virus-related liver failure. World J Gastroenterol 2020; 26(31): 4703-4717 [PMID: 32884227 DOI: 10.3748/wjg.v26.i31.4703] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i31/4703.htm |
| Number | Citing Articles |
| 1 |
Lili Zhang, Jianhua Hu, Chunyan Gou, Hua Jin, Chun Zhang, Yang Liu, Yitong Wang, Xiaojun Wang, Shin-ichi Yokota. Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. Mediators of Inflammation 2022; 2022 doi: 10.1155/2022/7794890
|
| 2 |
Fei Han, Yichao Zheng, Edwin Leeansyah. MAIT cells in chronic HBV infection‐related liver fibrosis: Friends or foes?. Clinical and Translational Discovery 2022; 2(4) doi: 10.1002/ctd2.154
|
| 3 |
Adiba I. Azad, Florencia Gutierrez, Gregory J. Gores. MAIT Cells in Liver Disease. Cells 2025; 15(1) doi: 10.3390/cells15010069
|
| 4 |
Tiao-Chun Cheng, Hong Xue, Han Li, Yi-Cun Liu, Li-Jun Tian, Zhao-Lian Bian, Feng-Song Chen. MAIT cells predict long-term prognosis in liver failure patients. Medicine 2022; 101(34) doi: 10.1097/MD.0000000000029809
|
| 5 |
Xin Zhang, Huafen Zhang, Haiyin Jiang, Hui Chen, Qinxian Chen. Meta-Analysis of Influencing Factors of Mortality in Chinese Patients with Liver Failure Undergoing Plasma Exchange. Blood Purification 2025; 54(6) doi: 10.1159/000545270
|
| 6 |
Liyuan Wang, Yuchen Fan. Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure. Infectious Diseases & Immunity 2022; 2(2) doi: 10.1097/ID9.0000000000000051
|
| 7 |
Bingying Du, Jiaming Teng, Rongkun Yin, Yuanyuan Tian, Tingwang Jiang, Yanan Du, Wei Cai. Increased Circulating T Follicular Helper Cells Induced via IL-12/21 in Patients With Acute on Chronic Hepatitis B Liver Failure. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.641362
|
| 8 |
Albert J Czaja. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease. World Journal of Gastroenterology 2021; 27(25): 3705-3733 doi: 10.3748/wjg.v27.i25.3705
|
| 9 |
Li-Ping Zhang, Hui-Fang Wang, Xing-Ran Zhai, Chun-Bao Zhou, Jin-Hong Yuan, Ye-Nv Ma, Zeng-Tao Yao, Shuo Huang, Wei-Zhe Li, Yan-Mei Jiao, Fu-Sheng Wang, Zheng-Sheng Zou, Ji-Yuan Zhang, Qing-Lei Zeng. Pyroptotic MAITs link microbial translocation with severity of alcohol-associated liver disease. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000159
|
| 10 |
Chie Sugimoto, Hiroshi Wakao. The Role of Mucosal-Associated Invariant T Cells in Viral Infections and Their Function in Vaccine Development. Vaccines 2025; 13(2) doi: 10.3390/vaccines13020155
|
| 11 |
Xingjie You, Leisheng Zhang, Kui Fang, Hanfei Huang, Yueyan Hu, Man Gu, Qiu Qu, Fenglin Xue, Shixin Huang, Zihan Wu, Huiping He, Linran Zeng, Yu Yang, Limin Chen, Jing Chen, Dan Pan, Hua Ma, Yuqi Wu, Siheng Long, Lirong Guo, Arifin Islam, Jie Li, Zhi Liu, Yuhui Liao, Hongju Yang. Inhibition of STAT1 alleviates MAIT cell dysfunction and attenuates disease progression in metabolic dysfunction-associated steatotic liver disease. Genes & Diseases 2026; doi: 10.1016/j.gendis.2026.102297
|
| 12 |
Maria Papanastasatou, Mihalis Verykokakis. Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1114605
|
| 13 |
Yiwen Shu, Sumeng Li, Yanqin Du, Xin Zheng. Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1611976
|
| 14 |
Oluwatomi Ibidapo-Obe, Tony Bruns. Tissue-resident and innate-like T cells in patients with advanced chronic liver disease. JHEP Reports 2023; 5(10) doi: 10.1016/j.jhepr.2023.100812
|
| 15 |
Jordi Yang Zhou. Innate immunity and early liver inflammation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1175147
|
| 16 |
Hejiao Zhang, Haiyuan Shen, Liangliang Zhou, Linxi Xie, Derun Kong, Hua Wang. Mucosal-Associated Invariant T Cells in the Digestive System: Defender or Destroyer?. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(4) doi: 10.1016/j.jcmgh.2022.12.014
|